Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) (PENUT)
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
A PHASE3 clinical study on Extreme Prematurity, this trial is completed. The trial is conducted by National Institute of Neurological Disorders and Stroke (NINDS) and has accumulated 15 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
▶ Show 10 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Aug 2020 — Sep 2020 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Nov 2019 — Aug 2020 [monthly]
Active Not Recruiting PHASE3
-
Sep 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE3
-
Oct 2018 — Sep 2019 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting PHASE3
-
Nov 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Feb 2017 — Nov 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .